Article
Germline Cancer Testing in Unselected Patients with Gastric and Esophageal Cancers: A Multi-center Prospective Study.
Digestive diseases and sciences - 1 Nov 2022
Uson P L S, Kunze K L, Golafshar M A, Botrus G, Riegert-Johnson D, Boardman L, Borad M J, Ahn D, Sonbol M B, Kahn A, Klint M, Esplin E D, Nussbaum R L, Stewart A K, Bekaii-Saab T, Samadder N J
Abstract excerpt
BACKGROUND AND AIMS: To determine prevalence and clinical utility of pathogenic germline variants (PGV) in gastric and esophageal cancer patients using universal genetic testing approach. METHODS: We undertook a prospective study of germline sequencing using an > 80 gene next-generation sequencing platform among patients with gastric and esophageal cancers receiving care at Mayo Clinic Cancer Center between April...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
